207 related articles for article (PubMed ID: 31718641)
1. Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells.
Cao W; Gao W; Zheng P; Sun X; Wang L
BMC Med Genomics; 2019 Nov; 12(1):163. PubMed ID: 31718641
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B.
Chi S; Liu Y; Zhou X; Feng D; Xiao X; Li W; Zhao Y; Wang H
Cancer Chemother Pharmacol; 2019 Feb; 83(2):277-287. PubMed ID: 30443761
[TBL] [Abstract][Full Text] [Related]
3. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
[TBL] [Abstract][Full Text] [Related]
4. [Influence of long-term treatment with MPA on the biological character of endometrial carcinoma Ishikawa cell].
Zhao SJ; Chen XJ; Feng YJ
Fen Zi Xi Bao Sheng Wu Xue Bao; 2007 Apr; 40(2):103-12. PubMed ID: 17580663
[TBL] [Abstract][Full Text] [Related]
5. [Study of mechanism of medroxyprogesterone 17-acetate on the cancer stem cell-like properties of human endometrial cancer].
Liu BJ; Li XP; Zhao LJ; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):772-7. PubMed ID: 24406136
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
Zhao S; Chen X; Lu X; Yu Y; Feng Y
Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
Xu Y; Tong J; Ai Z; Wang J; Teng Y
J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
[TBL] [Abstract][Full Text] [Related]
8. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
Niu YJ; Shi HR; Xie Y
Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-Mediated Gene Knockout of ARID1A Promotes Primary Progesterone Resistance by Downregulating Progesterone Receptor B in Endometrial Cancer Cells.
Wang H; Tang Z; Li T; Liu M; Li Y; Xing B
Oncol Res; 2019 Sep; 27(9):1051-1060. PubMed ID: 31072420
[TBL] [Abstract][Full Text] [Related]
10. NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB.
Cheng Y; Xie L; Xu Z; Hao M; Yang B; Shan W; Wang Y; Lv Q; Chen X
Cancer Gene Ther; 2022 Oct; 29(10):1452-1462. PubMed ID: 35388173
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.
Hanekamp EE; Kühne LM; Grootegoed JA; Burger CW; Blok LJ
Endocr Relat Cancer; 2004 Dec; 11(4):831-41. PubMed ID: 15613456
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
[TBL] [Abstract][Full Text] [Related]
13. Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate.
Zhao S; Li G; Yang L; Li L; Li H
Oncol Lett; 2013 Jan; 5(1):139-144. PubMed ID: 23255909
[TBL] [Abstract][Full Text] [Related]
14. Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer.
Wang Y; Zhang L; Che X; Li W; Liu Z; Jiang J
Arch Gynecol Obstet; 2018 Nov; 298(5):961-969. PubMed ID: 30206735
[TBL] [Abstract][Full Text] [Related]
15. Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer.
Hanekamp EE; Gielen SC; Smid-Koopman E; Kühne LC; de Ruiter PE; Chadha-Ajwani S; Brinkmann AO; Grootegoed JA; Burger CW; Huikeshoven FJ; Blok LJ
Clin Cancer Res; 2003 Sep; 9(11):4190-9. PubMed ID: 14519645
[TBL] [Abstract][Full Text] [Related]
16. The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth.
Nakamura M; Takakura M; Fujii R; Maida Y; Bono Y; Mizumoto Y; Zhang X; Kiyono T; Kyo S
Cancer Lett; 2013 Aug; 336(1):68-75. PubMed ID: 23603247
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and necrosis induced by novel realgar quantum dots in human endometrial cancer cells via endoplasmic reticulum stress signaling pathway.
Wang H; Liu Z; Gou Y; Qin Y; Xu Y; Liu J; Wu JZ
Int J Nanomedicine; 2015; 10():5505-12. PubMed ID: 26357474
[TBL] [Abstract][Full Text] [Related]
18. 5-aza-2'-deoxycytidine improves the sensitivity of endometrial cancer cells to progesterone therapy.
Hu Q; Yu L; Chen R; Wang YL; Ji L; Zhang Y; Xie Y; Liao QP
Int J Gynecol Cancer; 2012 Jul; 22(6):951-9. PubMed ID: 22683940
[TBL] [Abstract][Full Text] [Related]
19. Enhanced c-jun activity alters responsiveness to medroxyprogesterone acetate in Ishikawa human endometrial carcinoma cells.
Alkhalaf M; Murphy LJ; Murphy LC
Mol Endocrinol; 1993 Dec; 7(12):1634-41. PubMed ID: 8145769
[TBL] [Abstract][Full Text] [Related]
20. Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib.
Faigenbaum R; Haklai R; Ben-Baruch G; Kloog Y
Oncotarget; 2013 Feb; 4(2):316-28. PubMed ID: 23530112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]